TuisIMGN • BMV
add
ImmunoGen Ord Shs
Vorige sluiting
$268,50
Jaarwisseling
$268,50 - $268,50
Markkapitalisasie
8,72 mjd USD
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Inkomste | 113,42 m | 637,72% |
Bedryfskoste | 37,74 m | 12,26% |
Netto inkomste | 30,75 m | 139,54% |
Netto winsgrens | 27,11 | 105,36% |
Wins per aandeel | 0,10 | 132,26% |
EBITDA | 26,38 m | 134,26% |
Effektiewe belastingkoers | -3,94% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 605,54 m | 95,64% |
Totale bates | 822,10 m | 129,13% |
Totale aanspreeklikheid | 260,50 m | 44,09% |
Totale ekwiteit | 561,60 m | — |
Uitstaande aandele | 266,26 m | — |
Prys om te bespreek | 127,25 | — |
Opbrengs op bates | 8,45% | — |
Opbrengs op kapitaal | 10,17% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2023info | J/J-verandering |
---|---|---|
Netto inkomste | 30,75 m | 139,54% |
Kontant van bedrywe | 2,77 m | 104,31% |
Kontant van beleggings | -1,35 m | -124,92% |
Kontant van finansiering | 32,13 m | 7 056,35% |
Netto kontantverandering | 33,55 m | 152,12% |
Beskikbare kontantvloei | -2,32 m | 91,72% |
Meer oor
ImmunoGen, Inc. was a biotechnology company focused on the development of antibody-drug conjugate therapeutics for the treatment of cancer. ImmunoGen was founded in 1981 and was headquartered in Waltham, Massachusetts.
An ImmunoGen ADC contains a manufactured antibody that binds to a target found on cancer cells, with one of the company's potent cell-killing agents attached as a "payload". The antibody serves to deliver the cell-killing agent specifically to cancer cells bearing its target and the payload serves to kill these cells. In some cases, the antibody also has anticancer activity.
In November 2023, AbbVie, an American pharmaceutical company, announced it was buying ImmunoGen for $10.1 billion. Wikipedia
Gestig
1981
Webwerf
Werknemers
277